SCHEMBL25924729

SCHEMBL25924729

CN1CCC(CN2CCC3(CCNC3)C2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.56
CYP3A4 P08684 5/20 0.38
CYP2D6 P10635 5/20 0.38
CYP1A2 P05177 3/20 0.35
ALDH1A1 P00352 4/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
MAPK1 P28482 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
PDCD1LG2 Q9BQ51 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
KDM1A O60341 1/20 0.33
MAOB P27338 1/20 0.33
RCOR1 Q9UKL0 1/20 0.33
NCF1 P14598 1/20 0.33
L3MBTL3 Q96JM7 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
USP2 O75604 1/20 0.32
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24717722 0.91 TSHR (0.47) TSHRCYP3A4CYP2D6PDCD1LG2CD274
SCHEMBL22564921 0.91 TSHR (0.44) TSHRCYP3A4CYP2D6ALDH1A1CYP2C9
SCHEMBL27268957 0.88 TSHR (0.48) TSHRCYP3A4CYP2D6CYP1A2ALDH1A1
SCHEMBL25924736 0.86 TSHR (0.57) TSHRCYP3A4CYP2D6CYP1A2ALDH1A1
SCHEMBL27268150 0.84 TSHR (0.39) TSHRCYP3A4CYP2D6CYP1A2ALDH1A1
SCHEMBL13050540 0.84 TSHR (0.41) TSHRCYP3A4CYP2D6CYP1A2ALDH1A1
Hydrochloric Acid SCHEMBL484402 0.83 TSHR (0.41) TSHRCYP3A4CYP2D6CYP1A2ALDH1A1
SCHEMBL24480651 0.83 NCF1 (0.38) TSHROPRM1OPRL1NCF1SIGMAR1
SCHEMBL22564903 0.82 OPRM1 (0.42) TSHROPRM1OPRL1NCF1EPHX2
SCHEMBL27290168 0.81 NCF1 (0.39) TSHROPRM1OPRL1NCF1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112692-A1 CASITAS B-LINEAGE LYMPHOMA PROTOONCOGENE B (CBL-B) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-05-30 WO disclosed
WO-2023109892-A1 COMPOUND FOR INHIBITING OR DEGRADING BRD9, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 海思科医药集团股份有限公司 2023-06-22 WO disclosed